BRISE PHARMA
Brise Pharma operates in the scientific research and technical service industry.
BRISE PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
150 M CNY
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Aokai Zhihui Keji
Aokai Zhihui Keji is a scientific research and technical service industry.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Xinyu Hongtu
Xinyu Hongtu is a scientific research and technical service company.
Investors List
Sinopharm Capital
Sinopharm Capital investment in Angel Round - Brise Pharma
BioTrack Capital
BioTrack Capital investment in Angel Round - Brise Pharma
Qiming Venture Partners
Qiming Venture Partners investment in Angel Round - Brise Pharma
More informations about "Brise Pharma"
Brise Pharmaceuticals
Established in June 2021 in Shanghai, China. Brise Pharma stands as a clinical stage biopharmaceutical company with a major focus on the development of innovative and highly …See details»
Brise Pharma Company Profile 2024: Valuation, …
Brise Pharma General Information Description. Developer of new biopharmaceutical drugs designed for treating pain. The company focuses on the development of innovative and highly differentiated analgesic treatments for …See details»
Brise Pharma - Funding, Financials, Valuation & Investors
Brise Pharma operates in the scientific research and technical service industry. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...See details»
Brise Pharmaceuticals
Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for chronic pain, announced that the company’s pipeline BR007 has been granted Orphan Drug …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and
Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing with a total of …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre …
Apr 23, 2024 The organization's vision is to provide safe, effective, and accessible pain relief solutions for the multitude of patients worldwide grappling with poorly managed pain con …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre …
Apr 23, 2024 Brise Pharmaceuticals Co., LTD. (Brise), a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ …See details»
Brise Pharma - Products, Competitors, Financials, Employees ...
Publication date: Apr 29, 2024 Shanghai Brise Pharma completed Pre-A and Pre-A+ financings worth almost $20 million to advance clinical trials of two candidates for pain in the US and …See details»
Brise Pharma - Crunchbase
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry. Brise Pharma and Faron Pharmaceuticals share similar industries …See details»
Brise Pharmaceuticals
Recently, Brise Pharmaceuticals Co. Ltd. (Brise), a clinical-stage, pioneering company specializing in innovative treatments for acute and chronic pain, announced that Dr. Danny …See details»
Brise Pharmaceuticals raises nearly $20M in series Pre-A financing
Apr 23, 2024 Brise Pharmaceuticals Co., LTD. , a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre …
SHANGHAI, April 23, 2024 /PRNewswire/ -- Brise Pharmaceuticals Co., LTD.(Brise), a pioneering company specializing in innovative treatments for acute and chronic pain, has recently …See details»
Brise Pharma Closes $20 Million in A Rounds for Novel Pain Drugs
Shanghai Brise Pharma completed Pre-A and Pre-A+ financings worth almost $20 million to advance clinical trials of two candidates for pain in the US and China. The company develops …See details»
Brise Pharmaceuticals Raises Nearly $20M in Series Pre-A and Pre …
Apr 23, 2024 Brise Pharmaceuticals Co., LTD., a Shanghai, China-based company specializing in innovative treatments for acute and chronic pain, recently completed Pre-A and Pre-A+ …See details»
Brise Pharma Announces First Patient Dosed with BR01T in Phase I …
SHANGHAI, Oct. 18, 2023 /PRNewswire/ -- Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for chronic pain, has taken a significant step …See details»
Brise Pharma - Updates, News, Events, Signals & Triggers
Apr 22, 2024 Brise Pharma operates in the scientific research and technical service industry.See details»
Recombinant humanized anti-TrkA monoclonal antibody(Brise …
Nov 21, 2024 The primary objectives of this trial are to assess both the safety and effectiveness of the BR01T treatment in patients with chronic low back pain. Dr. Eric Liu, Chief Medical …See details»
Brise Pharma Announces First Patient Dosed with BR01T in Phase I …
Oct 19, 2023 SHANGHAI, China I October 18, 2023 I Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for chronic pain, has taken a …See details»
Countries to Resume Crucial Biodiversity Discussions in Rome, 25 …
2 days ago The UN Biodiversity Conference, suspended earlier this year in Cali, Colombia, will reconvene from 25-27 February, 2025 in Rome, Italy, at the headquarters of the Food and …See details»
Angel Round - Brise Pharma - 2021-10-01 - Crunchbase
Oct 1, 2021 Brise Pharma raised $23267718 on 2021-10-01 in Angel Round. vbdata.cn — Xiyuan Anjian announced the completion of 100 million yuan angel round financing, and …See details»